Collaborative drug therapy management by pharmacists - 2003

Pharmacotherapy

Volumn 23, Issue 9 I, 2003, Pages 1210-1225

  Hammond, Raymond W ^a   Schwartz, Amy H ^a   Campbell, Marla J ^a   Remington, Tami L ^a   Chuck, Susan ^a   Blair, Melissa M ^a   Vassey, Ann M ^a   Rospond, Raylene M ^a   Herner, Sheryl J ^a   Webb, C Edwin ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PRACTICE; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HUMAN; PATIENT CARE; PHARMACIST; REVIEW; TEAMWORK; UNITED STATES;

EID: 10744227395     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.23.10.1210.32752     Document Type: Review

References (46)

1. Carmichael JM, O'Connell MB, Devine B, et al. Collaborative drug therapy management by pharmacists. Pharmacotherapy 1997;17(5):1050-61.
2. Food and Drug Administration. New drug applications approved, 1998-2002. Available from http://www.fda.gov/cder. Accessed July 3, 2003.
3. Kohn LT, Corrigan JM, Donaldson MS, eds. To err is human: building a safer health system. Washington, DC: National Academy Press, 1999. Available from http://www.nap.edu/books/0309068371/html/. Accessed July 3, 2003.
4. Institute of Medicine. Crossing the quality chasm: a new health system for the 21st century. Washington, DC: National Academic Press, 2001:300. Available from http://nap.edu/books/0309072808/html/. Accessed July 3, 2003.
5. Hefler S, Levit K, Smith S, et al. Health spending growth up in 1999; faster growth expected in the future. Health Affairs 2001;20:193-203.
6. Keely JL, for the American College of Physicians-American Society of Internal Medicine. Pharmacist scope of practice. Ann Intern Med 2002;136:79-85.
7. Marks HM. Revisiting "the origins of compulsory drug prescriptions." Am J Public Health 1995;85:109-15.
8. Swann JP. FDA and the practice of pharmacy: prescription drug regulation before the Durham-Humphrey amendment of 1951. Pharm Hist 1994;36:55-70.
9. Short JC, Fairbanks LL, Kehoe WH Jr, et al. The pharmacist as a provider of primary care. Rockville, MD: National Center for Health Services Research and Development, 1975:II. (Contract no. HSM 110-HSRD, USPHS, April 1, 1973, to March 31, 1975.)
10. Copeland GP, Apgar DA. The pharmacist practitioner training program. Drug Intell Clin Pharm 1980;14:114-19.
11. Brands AJ. Treating ambulatory patients. US Pharm 1977;2:70-4.
12. Erickson SH. Primary care by a pharmacist in an outpatient clinic. Am J Hosp Pharm 1977;34:1086-90.
13. Thompson JF, McGhan WF, Ruffalo RL, Cohen DA, Adamcik B, Segal JL. Clinical pharmacists prescribing drug therapy in a geriatric setting: outcome of a trial. J Am Geriatr Soc 1984;32:154-9.
14. Health Manpower Pilot Projects. Final report to the legislature, state of California and the Healing Arts Licensing Boards. Prescribing and dispensing pilot projects. Office of Statewide Health Planning and Development, Division of Health Professions Development, November 1982.
15. An interview with Gordon Duffy, Assemblyman, 32nd District. CSHP Voice 1978:5;11.
16. California Assembly Bill 1868, 1981.
17. California Senate Bill 502, 1983.
18. California Assembly Bill 1759, 1994.
19. Christensen D, Fuller T, Williams D. Prescriptive authority protocols. 1993 Washington state survey. Washington State Board of Pharmacy, 1993.
20. Christensen D. Prescriptive authority for pharmacists: current status and future opportunities. Presented at the American Society of Hospital Pharmacists annual meeting, Reno, NV, June 5-9, 1994.
21. Flanagan ME. Update on state prescribing authority. Am Pharm 1995;NS35:12-18.
22. Heffler S, Smith S, Keehan S, Clemens MK, Won G, Zezza M. Health spending projections for 2002-2012. Health Tracking 2003:W3-54-W3-65. Available from www.healthaffairs.org/WebExclusives/Heffler_Web_Ext_020703.htm. Accessed July 3, 2003.
23. Agency for Healthcare Research and Quality. Patient safety task force fact sheet, April 2001. Available from http://www.ahrq.gov/qual/taskforce/psfactst.htm. Accessed July 3, 2003.
24. Bond CA, Raehl CL, Pitterle ME, Franke T. Health care professional staffing, hospital characteristics, and hospital mortality rates. Pharmacotherapy 1999;19:130-8.
25. Bond CA, Raehl CL, Franke T. Medication errors in United States hospitals. Pharmacotherapy 2001;21(9):1023-36.
26. Leape LL, Cullen DJ, Clapp MD, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA 1999;282:267-70.
27. Hilleman DE, Monaghan MS, Ashby CL, Mashni JE, Woolley K, Amato CM. Physician-prompting statin therapy intervention improves outcomes in patients with coronary heart disease. Pharmacotherapy 2001;21(11):1415-21.
28. Hitchcock AM, Lousberg TR, Merenich J. The impact of clinical pharmacy management on cardiovascular risk reduction in patients with established heart disease in a group model health maintenance organization [abstr]. Pharmacotherapy 2000;20:360-1.
29. Bluml BM, McKenney JM, Cziraky MJ. Pharmaceutical care services and results in project ImPACT: hyperlipidemia. J Am Pharm Assoc 2000;40:157-65.
30. Gattis WA, Hasselblad V, Whellan DJ, O'Connor CM. Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the pharmacist in heart failure assessment recommendation and monitoring (PHARM) study. Arch Intern Med 1999;159:1939-45.
31. Chiquette E, Amato MG, Bussey HI. Comparison of an anticoagulation clinic with usual medical care, anticoagulation control, patient outcomes, and health care costs. Arch Intern Med 1998;158:1641-7.
32. Rupp MT, McCallian DJ, Sheth KK. Developing and marketing a community pharmacy-based asthma management program. J Am Pharm Assoc 1997;NS37:694-9.
33. Grabenstein JD, Hartzema AG, Guess HA, Johnston WP. Community pharmacists as immunization advocates: a pharmacoepidemiologic experiment. Int J Pharm Prac 1993;2:5-10.
34. Fox AT, Tjhio DA, Teeters JH. Implementation of a pharmacy-based immunization program within a health care system [abstr]. Pharmacotherapy 2000;20:365.
35. Grabenstein JD, Hartzema AG, Guess HA, Johnston WP, Rittenhouse BE. Community pharmacists as immunization advocates: cost-effectiveness of a cue to influenza vaccination. Med Care 1992;30(6):503-13.
36. Munroe WR, Kunz K, Dalmady-Israel C, Potter L, Schonfeld W. Economic evaluation of pharmacist involvement in disease management in a community pharmacy setting. Clin Ther 1997;19:113-23.
37. Galt KA. Cost avoidance, acceptance, and outcomes associated with a pharmacotherapy consult clinic in a Veterans Affairs Medical Center. Pharmacotherapy 1998;18:1103-11.
38. Alliance for Pharmaceutical Care. Evidence of the value of the pharmacist. Available from http://www.accp.com/position/ paper6.pdf. Accessed July 3, 2003.
39. Pew Health Professions Commission. Critical challenges: revitalizing the health professions for the twenty-first century. San Francisco: UCSF Center for the Health Professions, 1995.
40. Pew Health Professions Commission. Recreating health professional practice for a new century, 4th report. Available from http://futurehealth.ucsf.edu/pdf_files/rept4.pdf. Accessed July 3, 2003.
41. The Robert Wood Johnson Foundation. Institute for the future: health and health care: the forecast, the challenge 2010. Available from http://www.rwjf.org/publications/publications Pdfs/iftf/index.htm. Accessed July 3, 2003.
42. Singhal PK, Raisch DW, Gupchup GV. The impact of pharmaceutical services in community and ambulatory care settings: evidence and recommendations for future research. Ann Pharmacother 1999;33:1336-55.
43. Carter BL, Helling DK. Ambulatory care pharmacy services: has the agenda changed? Ann Pharmacother 2000;34:772-87.
44. Schumock GT, Meek PD, Ploetz PA, Vermeulen LC, for the Publications Committee of the American College of Clinical Pharmacy. Economic evaluations of clinical pharmacy services-1988-1995. Pharmacotherapy 1996;16(6): 1188-208.
45. Schumock GT, Butler MG, Meek PD, Vermeulen LC, Arondekar BV, Bauman JL, for the 2002 Task Force on Economic Evaluation of Clinical Pharmacy Services of the American College of Clinical Pharmacy. Evidence of the economic benefit of clinical pharmacy services: 1996-2000. Pharmacotherapy 2003;23(1):113-32.
46. Infectious Diseases Society of America. Position statement. Hospital pharmacists and infectious disease specialists. Clin Infect Dis 1997;25:802.